Drug Shortage Report for POTASSIUM ACETATE INJECTION USP

Last updated on 2020-01-08 History
Report ID 98415
Drug Identification Number 02362597
Brand name POTASSIUM ACETATE INJECTION USP
Common or Proper name Potassium Acetate Injection
Company Name OMEGA LABORATORIES LIMITED
Market Status MARKETED
Active Ingredient(s) POTASSIUM ACETATE
Strength(s) 39.2%
Dosage form(s) LIQUID
Route of administration INTRAVENOUS
Packaging size 10 x 50mL vial / fiole
ATC code B05XA
ATC description I.V. SOLUTION ADDITIVES
Reason for shortage Disruption of the manufacture of the drug.
Anticipated start date
Actual start date 2019-10-09
Estimated end date 2019-12-15
Actual end date 2019-12-19
Shortage status Resolved
Updated date 2020-01-08
Company comments On allocation
Health Canada comments
Tier 3 Status No
Contact Address 11177 HAMON
MONTREAL, QUEBEC
CANADA H3M 3E4
Company contact information info@omegalaboratory.com - 1-800-363-0584

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v4 2020-01-08 French Compare
v3 2020-01-08 English Compare
v2 2019-11-11 French Compare
v1 2019-11-11 English Compare

Showing 1 to 4 of 4